The rise in cases follows at least a majority (69%) of Georgia residents receiving a COVID vaccine as of May, raising questions about the vaccine's efficacy.
As of the conclusion of the prior year, the firm, with its linked enterprises holding assets in the U.S., declared outstanding liabilities amounting to $335 billion.
